Endologix Inc (ELGX) 13.00 $ELGX
Health Care Sector Stocks Technical Data -- Research on Bacterin International Holdings, Align Technology, Endologix, and Unilife
PR Newswire - Mon May 12, 11:30AM CDT
On Friday, May 09, 2014, the NASDAQ Composite ended at 4,071.87, up 0.50%, the Dow Jones Industrial Average finished the session at 16,583.34, up 0.20% and the S&P 500 closed at 1,878.48, up 0.15%. During the trading session, six out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 668.35, up 0.58%, and the index has gained 3.66% in the previous one month. Investor-Edge has initiated coverage on the following equities: Bacterin International Holdings Inc. (NYSE MKT: BONE), Align Technology Inc. (NASDAQ: ALGN), Endologix Inc. (NASDAQ: ELGX) and Unilife Corp. (NASDAQ: UNIS). Free technical research on BONE, ALGN, ELGX and UNIS can be downloaded upon signing up at:
Endologix to Participate in Two Investor Conferences in May
GlobeNewswire - Fri May 02, 8:00AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chairman and Chief Executive Officer, and Shelley Thunen, Chief Financial Officer, are scheduled to participate at two investor conferences in May. The first conference is the Deutsche Bank 39 Annual Health Care Conference in Boston, MA.
Endologix Reports 12% Global Revenue Growth for the First Quarter 2014
GlobeNewswire - Wed Apr 30, 3:12PM CDT
Europe Revenue Growth Exceeds 90%
Endologix, Inc. Partners with Terso Solutions, Inc. for Fully Automated Nellix Inventory at Medical Facilities Worldwide
PR Newswire - Tue Apr 29, 12:48PM CDT
Terso Solutions, Inc., a leading provider of automated inventory management solutions for healthcare and life science, today announced that Endologix, Inc. (Nasdaq: ELGX) has partnered with them for a fully automated, on-site consignment inventory program. Endologix chose Terso Solutions, Inc. because of their proven track record with both RFID solutions for medical device inventory management and cold chain security.
Endologix Has Returned 11.4% Since SmarTrend Recommendation (ELGX)
Comtex SmarTrend(R) - Fri Apr 25, 9:40AM CDT
SmarTrend identified a Downtrend for Endologix (NASDAQ:ELGX) on February 28th, 2014 at $13.41. In approximately 2 months, Endologix has returned 11.38% as of today's recent price of $11.88.
Zacks Rank #5 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
Endologix to Report First Quarter 2014 Financial Results on April 30, 2014
GlobeNewswire - Mon Apr 21, 3:07PM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its first quarter 2014 financial results, which will take place on Wednesday, April 30, 2014 after the close of the market.
Endologix Shares Down 10.5% Since SmarTrend's Sell Call (ELGX)
Comtex SmarTrend(R) - Wed Apr 16, 9:27AM CDT
SmarTrend identified a Downtrend for Endologix (NASDAQ:ELGX) on February 28th, 2014 at $13.41. In approximately 2 months, Endologix has returned 10.48% as of today's recent price of $12.00.
Health Care Sector Equities Update -- Research on Endologix, Align Technology, Spectranetics, and Unilife
PR Newswire - Mon Apr 14, 8:00AM CDT
The trading session on Friday, April 11, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,026.75, down 0.89% and the NASDAQ Composite closed at 3,999.73, down 1.34%. The S&P 500 finished the session 0.95% lower at 1,815.69. The losses were broad based as all the ten sectors posted losses. The S&P 500 Health Care Sector Index finished the day at 644.74, down 1.07%, and the same has declined 2.36% in last three months. Investor-Edge has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Align Technology Inc. (NASDAQ: ALGN), Spectranetics Corp. (NASDAQ: SPNC) and Unilife Corp. (NASDAQ: UNIS). Free technical research on ELGX, ALGN, SPNC and UNIS can be downloaded upon signing up at:
Bear of the Day: Endologix (ELGX) - Bear of the Day
Neena Mishra - ZACKS - Wed Mar 26, 2:31AM CDT
Bear of the Day: Endologix (ELGX) - Bear of the Day
Upgrade Alert for Endologix (ELGX)
Comtex SmarTrend(R) - Fri Mar 21, 8:00AM CDT
Endologix (NASDAQ:ELGX) was upgraded from Neutral to Buy at BTIG today. The stock closed yesterday at $12.96 on volume of 974,000 shares, below average daily volume of 995,000. Endologix, Inc. develops, manufactures, sells, and markets minimally invasive treatments for vascular diseases. The Company's products include the Powerlink System, a catheter-based endoluminal stent graft that treats abdominal aortic aneurysms. Endologix's products are sold in the United States as well as international markets.
Moving Average Crossover: Great News for Endologix (ELGX)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 6:47AM CDT
Moving Average Crossover: Great News for Endologix (ELGX)?
Why Endologix (ELGX) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:43AM CDT
It may be a good decision to sell Endologix as its price dropped significantly in the past four weeks, the stock witnessed a negative trend in earnings estimate revisions and a poor Zacks Rank confirms weakness.
Endologix to Participate in Two Investor Conferences in March
GlobeNewswire - Fri Mar 07, 2:59AM CST
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chairman and Chief Executive Officer, and Shelley Thunen, Chief Financial Officer, are scheduled to participate at two investor conferences in March. The first conference is the 26th Annual ROTH Conference in Dana Point, CA.
Nasdaq stocks posting largest volume increases
AP - Fri Feb 28, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage decreases
AP - Fri Feb 28, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Why Endologix Inc. Shares Were Clobbered
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 28, 12:53PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Endologix , a developer of medical devices...
Will This Downgrade Hurt Endologix (ELGX) Today?
at The Street - Fri Feb 28, 8:45AM CST
Oppenheimer downgraded Endologix (ELGX) to "perform" from "outperform" and set a $16 target price. The firm noted domestic business is facing increased competition.
Health Care Sector Stocks Technical Data -- Research on Bacterin International Holdings, Align Technology, Endologix, and Unilife
PR Newswire - Mon May 12, 11:30AM CDT
On Friday, May 09, 2014, the NASDAQ Composite ended at 4,071.87, up 0.50%, the Dow Jones Industrial Average finished the session at 16,583.34, up 0.20% and the S&P 500 closed at 1,878.48, up 0.15%. During the trading session, six out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 668.35, up 0.58%, and the index has gained 3.66% in the previous one month. Investor-Edge has initiated coverage on the following equities: Bacterin International Holdings Inc. (NYSE MKT: BONE), Align Technology Inc. (NASDAQ: ALGN), Endologix Inc. (NASDAQ: ELGX) and Unilife Corp. (NASDAQ: UNIS). Free technical research on BONE, ALGN, ELGX and UNIS can be downloaded upon signing up at:
Endologix to Participate in Two Investor Conferences in May
GlobeNewswire - Fri May 02, 8:00AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chairman and Chief Executive Officer, and Shelley Thunen, Chief Financial Officer, are scheduled to participate at two investor conferences in May. The first conference is the Deutsche Bank 39 Annual Health Care Conference in Boston, MA.
Endologix Reports 12% Global Revenue Growth for the First Quarter 2014
GlobeNewswire - Wed Apr 30, 3:12PM CDT
Europe Revenue Growth Exceeds 90%
Endologix, Inc. Partners with Terso Solutions, Inc. for Fully Automated Nellix Inventory at Medical Facilities Worldwide
PR Newswire - Tue Apr 29, 12:48PM CDT
Terso Solutions, Inc., a leading provider of automated inventory management solutions for healthcare and life science, today announced that Endologix, Inc. (Nasdaq: ELGX) has partnered with them for a fully automated, on-site consignment inventory program. Endologix chose Terso Solutions, Inc. because of their proven track record with both RFID solutions for medical device inventory management and cold chain security.
Endologix Has Returned 11.4% Since SmarTrend Recommendation (ELGX)
Comtex SmarTrend(R) - Fri Apr 25, 9:40AM CDT
SmarTrend identified a Downtrend for Endologix (NASDAQ:ELGX) on February 28th, 2014 at $13.41. In approximately 2 months, Endologix has returned 11.38% as of today's recent price of $11.88.
Zacks Rank #5 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
Endologix to Report First Quarter 2014 Financial Results on April 30, 2014
GlobeNewswire - Mon Apr 21, 3:07PM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its first quarter 2014 financial results, which will take place on Wednesday, April 30, 2014 after the close of the market.
Endologix Shares Down 10.5% Since SmarTrend's Sell Call (ELGX)
Comtex SmarTrend(R) - Wed Apr 16, 9:27AM CDT
SmarTrend identified a Downtrend for Endologix (NASDAQ:ELGX) on February 28th, 2014 at $13.41. In approximately 2 months, Endologix has returned 10.48% as of today's recent price of $12.00.
Health Care Sector Equities Update -- Research on Endologix, Align Technology, Spectranetics, and Unilife
PR Newswire - Mon Apr 14, 8:00AM CDT
The trading session on Friday, April 11, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,026.75, down 0.89% and the NASDAQ Composite closed at 3,999.73, down 1.34%. The S&P 500 finished the session 0.95% lower at 1,815.69. The losses were broad based as all the ten sectors posted losses. The S&P 500 Health Care Sector Index finished the day at 644.74, down 1.07%, and the same has declined 2.36% in last three months. Investor-Edge has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Align Technology Inc. (NASDAQ: ALGN), Spectranetics Corp. (NASDAQ: SPNC) and Unilife Corp. (NASDAQ: UNIS). Free technical research on ELGX, ALGN, SPNC and UNIS can be downloaded upon signing up at:
Bear of the Day: Endologix (ELGX) - Bear of the Day
Neena Mishra - ZACKS - Wed Mar 26, 2:31AM CDT
Bear of the Day: Endologix (ELGX) - Bear of the Day
Upgrade Alert for Endologix (ELGX)
Comtex SmarTrend(R) - Fri Mar 21, 8:00AM CDT
Endologix (NASDAQ:ELGX) was upgraded from Neutral to Buy at BTIG today. The stock closed yesterday at $12.96 on volume of 974,000 shares, below average daily volume of 995,000. Endologix, Inc. develops, manufactures, sells, and markets minimally invasive treatments for vascular diseases. The Company's products include the Powerlink System, a catheter-based endoluminal stent graft that treats abdominal aortic aneurysms. Endologix's products are sold in the United States as well as international markets.
Moving Average Crossover: Great News for Endologix (ELGX)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 6:47AM CDT
Moving Average Crossover: Great News for Endologix (ELGX)?
Why Endologix (ELGX) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:43AM CDT
It may be a good decision to sell Endologix as its price dropped significantly in the past four weeks, the stock witnessed a negative trend in earnings estimate revisions and a poor Zacks Rank confirms weakness.
Endologix to Participate in Two Investor Conferences in March
GlobeNewswire - Fri Mar 07, 2:59AM CST
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chairman and Chief Executive Officer, and Shelley Thunen, Chief Financial Officer, are scheduled to participate at two investor conferences in March. The first conference is the 26th Annual ROTH Conference in Dana Point, CA.
Nasdaq stocks posting largest volume increases
AP - Fri Feb 28, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage decreases
AP - Fri Feb 28, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Why Endologix Inc. Shares Were Clobbered
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 28, 12:53PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Endologix , a developer of medical devices...
Will This Downgrade Hurt Endologix (ELGX) Today?
at The Street - Fri Feb 28, 8:45AM CST
Oppenheimer downgraded Endologix (ELGX) to "perform" from "outperform" and set a $16 target price. The firm noted domestic business is facing increased competition.
